How does Hedge fund guru Dmitry Balyasny’s choice to invest new stakes in Teva Pharmaceutical (NYSE:TEVA) and Synergy Pharmaceuticals (NASDAQ:SGYP) while bumping up his position in Opko Health (NASDAQ:OPK) in a big way measure up against the Street? Let’s take a closer look:
Story Continues